Journal of Alzheimer's Disease
Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?

TitleDiabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?
Publication TypeJournal Article
Year of Publication2017
AuthorsSquitti, R, Mendez, AJ, Simonelli, I, Ricordi, C
JournalJ Alzheimers Dis
Volume56
Issue3
Pagination1055-1064
Date Published2017
ISSN1875-8908
Abstract

BACKGROUND: Defective copper regulation, primarily referred to as chelatable redox active Cu(II), has been involved in the etiology of diabetes, and Alzheimer's disease (AD).

OBJECTIVES: However, no study has determined levels of labile copper non-bound to ceruloplasmin (non-Cp Cu, also known as 'free' copper) in the blood of subjects with diabetes compared with that of AD patients.

METHODS: To this aim, values of non-Cp Cu were measured in 25 Type 1 (T1D) and 31 Type 2 (T2D) subjects and in28 healthy controls, along with measurements of C-reactive protein, glycated hemoglobin A1c, cholesterol, and triglycerides. Non-Cp Cu levels were compared with those of an AD group previously studied.

RESULTS: T2D subjects had significantly higher non-Cp Cu levels than Controls and T1D subjects (both p 

CONCLUSION: These results suggest the involvement of catalytically-active Cu(II) and glucose dysregulation in oxidative stress reactions leading to tissue damage in both diseases.

DOI10.3233/JAD-161033
Alternate JournalJ. Alzheimers Dis.
PubMed ID27983558
PubMed Central IDPMC5302029
E-mail Icon
Comment Icon
  • Comment
Bookmark Icon Bookmark Recommend Icon Recommend Follow Icon Follow
  • Comment
| Bookmark | Recommend | Follow

Source URL: https://www.j-alz.com/content/diabetes-and-alzheimers-disease-can-elevated-free-copper-predict-risk-disease